Microarray data—the US FDA, industry and academia
暂无分享,去创建一个
[1] Emanuel F. Petricoin,et al. Medical applications of microarray technologies: a regulatory science perspective , 2002, Nature Genetics.
[2] Shiew-Mei Huang,et al. Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA‐PWG‐PhRMA‐DruSafe Workshop , 2003, Journal of clinical pharmacology.